Skip to content
healthcare.dev

Cisatracurium Besylate

NDC 0143-9397, Cisatracurium Besylate, injection, from Hikma Pharmaceuticals USA Inc..

Product NDC
0143-9397
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203079
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9397 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
0143-9397-100014393971010 VIAL in 1 CARTON (0143-9397-10) / 10 mL in 1 VIAL (0143-9397-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/46c815f6-7a3d-43a3-b470-3377b126ba09

Use it

Look up 0143-9397 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9397 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0143-9397. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.